Novo Nordisk plans to start late-stage trials for experimental obesity drug amycretin-February 2024-www.financetom.com

Novo Nordisk plans to start late-stage trials for experimental obesity drug amycretin

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Novo Nordisk plans to start late-stage trials for experimental obesity drug amycretin

Jun 12, 2025 10:41 AM

June 12 (Reuters) - Novo Nordisk said on

Thursday it plans to start late-stage trials of amycretin

injection and oral drugs during the first quarter of 2026 for

adults who are overweight or obese.

Previous page： Here's what key voices from the world of business and markets told CNBC-TV18 today Next page： Yes Bank repays Rs 35K cr out of Rs 50K cr borrowed via RBI's special liquidity facility

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Here's what key voices from the world of business and markets told CNBC-TV18 today

Aug 18, 2020

Demand for the LCV and ICV is expected to pick up slowly in October and November. Heavy vehicle demand may...

Yes Bank repays Rs 35K cr out of Rs 50K cr borrowed via RBI's special liquidity facility

Aug 18, 2020

Yes Bank has repaid the Reserve Bank of India (RBI) Rs 35,000 crores out of the Rs 50,000 crores of...

Petronet LNG net profit slips 7% in Q1

Aug 18, 2020

Average gas send-out from Petronet's 17.5 million tonne a year Dahej LNG import terminal fell to less than 60 percent of the capacity in April, down from over 88 percent in the previous month.

Gujarat govt approves construction of high-rises of over 70 floors

Aug 18, 2020

he plot size to construct a skyscraper having a height between 100 to 150 metres must be 2,500 sqm, and 3,500 sqm if the proposed height is above 150 metres.